T cell malignancies after CAR T cell therapy in the DESCAR-T registry
Of 3,066 patients:
(2,536 B cell lymphoma, 162 ALL, 368 MM)
ONLY 1 (0.03%) pt dev a T cell malignancy after CAR T infusion
@RemyDulery
Roch Houot
@NatureMedicine
pubmed.ncbi.nlm.nih.gov/39779930/
pubmed.ncbi.nlm.nih.gov
T cell malignancies after CAR T cell therapy in the DESCAR-T registry - PubMed
The risk of T cell malignancies after chimeric antigen receptor (CAR) T cell therapy is a concern, although the true incidence remains unclear. Here we analyzed the DESCAR-T registry database, encompa...
